登革病毒IgG/IgM诊断试剂盒 返回列表页

Panbio登革病毒IgG/IgM诊断试剂盒

广州健仑生物科技有限公司

本公司为大家供应各种进口品牌登革热检测试剂盒，包括澳洲Panbio、美国NovaBios、美国CORTEZ等美国CDC品牌。主要包括胶体金、酶免、PCR等方法学。欢迎咨询

Panbio登革病毒IgG/IgM诊断试剂盒

非洲工作用登革热试纸

热带国家旅游用登革热检测试纸

登革热IgM抗体、登革热IgG抗体、登革热NS1抗原、登革热早期检测试剂盒

登革热核酸检测试剂盒

Panbio公司简介:
1、1988年成立，2001年在澳大利亚证券交易所上市。
2、Panbio系关于虫媒感染性疾病及热带感染性疾病的专业供货商。
3、产品面向虫媒感染性疾病的检测，在国内疾控系统具有*的认知和认可度。
4、2010年销售800万检测试剂，为30多种疾病提供诊断。

Panbio登革热介绍：

1、登革热快速检测试剂(Dengue Duo Cassette R-DEN03D)
用于定性的快速检测人群血清、血浆或全血中登革病毒的IgM及IgG抗体。可在15分钟内检测结果。

2、登革IgM捕捉ELISA(Dengue IgM Capture ELISA E-DEN01M)
用于定性的检测人群血清中登革病毒的IgM抗体，用于临床实验室对具有持续发烧的登革热症状的病人的辅助诊断。

3、登革IgG捕捉ELISA(Dengo IgG Capture ELISA E-DEN02G)
用于定性检测血清中登革病毒(血清型1、2、3及4型)的IgG抗体。用于临床实验室对继发登革热感染的辅助诊断。

4、登革早期ELISA(Dengue Early ELISA E-DEN01P)
用于定性检测血清中登革病毒的NS1抗原(血清型1、2、3及4型)。用于临床实验室对有持续发烧的登革热症状病人的辅助性诊断。

5、登革IgG间接ELISA(Dengue IgG Indirect ELISA E-DEN01G)
用于定性检测血清中登革病毒(血清型1、2、3及4型)的IgG抗体，用于临床实验室对具有持续发烧的登革感染症状或接触史的患者的辅助性诊断。

6、登革IgM & IgG联检ELISA(Dengue Duo IgM & IgG Capture ELISA E-DEN01D)
用于定性检测血清中登革病毒的IgM和IgG抗体。可以区分原发感染与继发感染。

Dengue产品介绍

Panbio

Panbio登革热 - 威胁Panbio登革热是影响儿童zui严重的疾病之一热带地区是由蚊子造成的病毒与那些造成相关的病毒黄热病和西尼罗河。更多超过世界人口的40％生活在Panbio登革热流行地区和一年多达1亿人变得感染每年都有大概有50万例孩子，可能是致命的Panbio登革热出血热。这份公告是*个定期报告Panbio登革热报告。我们的目的是为您提供预防Panbio登革热努力的简明扼要的资料，特别是中心的作用疾病控制与预防（CDC）在这些努力中。在个*的问题上，我们专注于威胁Panbio登革热到美国Panbio登革热世界传播首先，有一点背景。Panbio登革热是由四个密切相关的病毒引起的，通常被称血清型（Panbio登革热-1，-2，-3和-4）。感染一种血清型可引起终身免疫力，但仅限于此血清型有证据表明随后的另一种血清型感染增加了机会发展Panbio登革热出血热或Panbio登革热休克综合征。通常，一种血清型的流行是随后几年后，其他一个流行病。以东南亚为例，大多数青少年已经暴露于多种类型。Panbio登革热病毒在人类之间的传播主要是“黄热病蚊子”的工作，埃及伊蚊。一个黑色的小黑色蚊子，带有白色斑纹，埃及伊蚊在所有的除了zui冷的外都兴旺发达在范围内，包括美国南部的大部分地区。女性通常8-12天蚊子在感染的人身上饲养，它可以将病毒传给另一个人。埃及伊蚊通常在白天叮咬，是*的适应生活在人类和周围人类的栖息地人造容器中的鸡蛋，如宠物水碗，花瓶和废弃的塑料垃圾。还没有一个Panbio登革热疫苗和控制蚊子“载体”是防止传播的*方法。虽然非常有用，但是有效的蚊子控制难以维持。在未来的问题上，我们将讨论工作正在开发疫苗和创新的蚊虫防治方法。他的研究和公共卫生利益集中在新的评估和引进
疫苗，肝炎病毒的分子流行病学和循证发展
公共卫生政策。玛格丽斯博士是180位同行评议的作者或合着者
出版物，包括35本书章或诉讼。我们热情地欢迎Hal回到CDC和
期待他在与Panbio登革热的斗争中的。
CDCPanbio登革热科
美国的一些疾病和其他国家一样，
必须由医师和医院报告公共卫生
当局作为建立基线发生的手段
的疾病或病症。以这种方式增加以上
基线将及时引发公共卫生反应。这个
对传染病尤其重要，因为它
允许当局提醒社区增加
健康风险，采取行动保护公众。在里面
美国CDC负责收集和分析这些
数据。 2009年6月前，Panbio登革热不是可报告的疾病
在美国根据国务委员会的建议
和领土流行病学家（CSTE），Panbio登革热病毒
感染，包括Panbio登革热和Panbio登革热出血
发烧，于2010年1月份报告。
2007年，居住在大陆的美国人中有超过10,500例Panbio登革热病例报告
美国及其领土。其中许多案件发生在400万美国居民居民当中
在波多黎各，美属维京群岛和美国太平洋地区。不过，有几例
在加勒比，墨西哥的Panbio登革热流行国家返回美国大陆的旅客中，
中南美洲，亚太地区。显然，Panbio登革热对公众的风险增加
健康在美国。

Panbio

我司还提供其它进口或国产试剂盒：登革热、疟疾、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的Panbio产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

references：

Panbio dengue fever - global threat Panbio dengue is one of the most serious diseases affecting children. Tropical areas are caused by mosquitoes with viruses associated with those who cause yellow fever and the West Nile. More than 40% of the world's population live in the Panbio dengue epidemic area and as many as 100 million people a year become infected every year about 500,000 children, probably deadly Panbio dengue fever haemorrhagic fever. This announcement is the first periodic report of the Panbio dengue report. Our aim is to provide you with concise and concise information on the global efforts to prevent Panbio dengue efforts, especially the role of the Center for Disease Control and Prevention (CDC) in these efforts. On the first issue, we focus on threatening Panbio dengue to the United States Panbio dengue world spread first, with a little background. Panbio dengue is caused by four closely related viruses, commonly referred to as serotypes (Panbio dengue-1, -2, -3 and -4). Infection of a serotype can cause lifelong immunity, but only in this serotype There is evidence that subsequent serotype infections have increased the chances of developing Panbio dengue hemorrhagic fever or Panbio dengue fever syndrome. Often, a serotype of the epidemic is followed by a few other years after the epidemic. In Southeast Asia, for example, most adolescents have been exposed to multiple types. Panbio dengue virus spread among humans mainly "yellow fever mosquito" work, Aedes aegypti. A black little black mosquito with white markings, Aedes aegypti is thriving all over the world except for the coldest, including most parts of the southern United States. Women usually 8-12 days of mosquitoes are reared in infected people, it can pass the virus to another person. Aedes mosquitoes usually bite during the day and are uniquely adapted to live in humans and humans around the human habitat of artificial containers such as pet water bowls, vases and abandoned plastic waste. There is not a Panbio dengue vaccine and control mosquito "carrier" is the only way to prevent the spread. Although it is very useful, effective mosquito control is difficult to maintain. In future issues, we will discuss the work being developed for vaccines and innovative methods of mosquito control. His research and public health benefits are focused on new assessments and introductions
Vaccine, molecular epidemiology and evidence-based development of hepatitis virus
Public health policy. Dr. Margaret is the author or co-author of 180 peer reviewers
Publications, including 35 books or litigation. We warmly welcome Hal back to CDC and
Looking forward to his leadership in the fight against Panbio dengue fever.
CDCPanbio dengue division
Some of the diseases in the United States, like other countries,
Public health must be reported by physicians and hospitals
The authorities act as a means of establishing a baseline
Of the disease or condition. In this way increase above
The baseline will trigger a public health response in a timely manner. This one
It is especially important for infectious diseases because of it
Allow the authorities to remind the community to increase
Health risks, take action to protect the public. inside
The US CDC is responsible for collecting and analyzing these
data. By June 2009, Panbio dengue fever was not a reportable disease
In the United States according to the recommendations of the Council of State
And territorial epidemiologists (CSTE), Panbio dengue virus
Infections, including Panbio dengue fever and Panbio dengue fever
Fever, reported in January 2010.
In 2007, more than 10,500 cases of Panbio dengue fever were reported among Americans living in the mainland
The United States and its territory. Many of these cases occurred among the 4 million inhabitants of the United States
In Puerto Rico, the US Virgin Islands and the US Pacific region. However, there are several cases
In the Caribbean, the Mexican Panbio dengue epidemic country returned to the American mainland,
Central and South America, Asia Pacific. Obviously, Panbio dengue fever increases the risk to the public
Health in the United States.